Synthetic Genomics, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence

Synthetic Genomics, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Synthetic Genomics, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence
Synthetic Genomics, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Published Sep 23, 2016
25 pages — Published Sep 23, 2016
Price US$ 250.00  |  Buy this Report Now

About This Report

  
Abstract:

Summary

Synthetic Genomics, Inc. (Synthetic Genomics) is a synthetic biology company that develops and commercializes new genomic-driven bio-energy and biochemical solutions. The companys products and services include DNA synthesis services, instrumentation, reagents, and bioinformatics services and software. It provides solutions in genomics research, bioproduction, and applied products. Synthetic Genomics caters its genomics solutions for academic and commercial research and development organizations. It focuses on the production of nutritionals, pharmaceuticals, vaccines, and bio-industrial products derived from renewable biological resources.

Synthetic Genomics, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharmaceuticals & Healthcare eTrack deals database, and primary and secondary research.


Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.


Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed informat

  
Source:
Document ID
GDPH170465D
Country
Industry
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
Table of Contents23
  List of Tables31
  List of Figures41
Synthetic Genomics, Inc., Pharmaceuticals &Healthcare, Deals By Year, 2010 to YTD 201642
Synthetic Genomics, Inc., Pharmaceuticals &Healthcare Deals By Type, 2010 to YTD 201661
Synthetic Genomics, Inc., Pharmaceuticals &Healthcare, Deals By Region, 2010 to YTD 201671
Synthetic Genomics, Inc., Pharmaceuticals &Healthcare, Deals By Therapy Area, 2010 to YTD 201681
Synthetic Genomics, Inc., Pharmaceuticals &Healthcare, Deals Summary, 2010 to YTD 201691
Synthetic Genomics, Inc., Pharmaceuticals &Healthcare, Deal Details1011
  Asset Purchase101
    Synthetic Genomics Acquires DNA Technology Patent Portfolio From febit101
  Venture Financing111
    Synthetic Genomics Raises US$10 Million In Venture Financing111
  Partnerships121
    Synthetic Genomics Expands R&D Agreement with Lung Biotech121
    SGI-DNA Enters Into Agreement With Integrated DNA Technologies For Synthetic DNA Products131
    Synthetic Genomics Enters Into Joint Venture Agreement With J. Craig Venter Institute141
  Licensing Agreements151
    Synthetic Genomics Enters Licensing Agreement with Gen9 for Synthetic Biology Technology Patents151
    New England Biolabs Enters Into Licensing Agreement With Synthetic Genomics161
  Equity Offering171
    Synthetic Genomics Raises USD50 Million in Private Placement of Shares171
    Synthetic Genomics Raises USD50 Million in Private Placement of Shares181
  Acquisition191
    Monsanto Invests In Synthetic Genomics, Developer Of Genomic-Driven Solutions191
    Synthetic Genomics Secures An Additional US$35 Million Investment From Life Technologies201
Synthetic Genomics, Inc. - Key Competitors211
Key Employees222
Locations And Subsidiaries241
  Head Office241
  Other Locations &Subsidiaries241
Appendix251
  Methodology251
  About GlobalData251
  Contact Us251
  Disclaimer251

Table Of Contents

About the Author


Cite this Report

  
MLA:
GlobalData Financial Mergers and Acquisitions Intelligence. "Synthetic Genomics, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile" Sep 23, 2016. Alacra Store. Nov 16, 2026. <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/Synthetic-Genomics-Inc-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-7757>
  
APA:
GlobalData Financial Mergers and Acquisitions Intelligence. (2016). Synthetic Genomics, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile Sep 23, 2016. New York, NY: Alacra Store. Retrieved Nov 16, 2026 from <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/Synthetic-Genomics-Inc-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-7757>
  
US$ 250.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research